{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,11]],"date-time":"2026-04-11T03:55:38Z","timestamp":1775879738587,"version":"3.50.1"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,2,29]],"date-time":"2020-02-29T00:00:00Z","timestamp":1582934400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,2,29]],"date-time":"2020-02-29T00:00:00Z","timestamp":1582934400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Gastrointest Canc"],"published-print":{"date-parts":[[2021,3]]},"DOI":"10.1007\/s12029-020-00376-1","type":"journal-article","created":{"date-parts":[[2020,2,29]],"date-time":"2020-02-29T04:56:14Z","timestamp":1582952174000},"page":"177-186","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Tumor Microenvironment Mediators CD8+- and FOXP3+-Labeled T Lymphocytes Are Prospective Prognosticators in Curatively Treated Rectal Cancer Patients"],"prefix":"10.1007","volume":"52","author":[{"given":"Hala","family":"Zaghloul","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ahmed","family":"Abbas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dina","family":"Abdulah","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2020,2,29]]},"reference":[{"key":"376_CR1","doi-asserted-by":"publisher","first-page":"7","DOI":"10.3322\/caac.21332","volume":"66","author":"RL Siegel","year":"2016","unstructured":"Siegel RL, Miller KD, Jemal A. Cancer statistics, 2016. CA Cancer J Clin. 2016;66:7\u201330. https:\/\/doi.org\/10.3322\/caac.21332.","journal-title":"CA Cancer J Clin"},{"key":"376_CR2","doi-asserted-by":"publisher","first-page":"394","DOI":"10.3322\/caac.21492","volume":"68","author":"F Bray","year":"2018","unstructured":"Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018;68:394\u2013424. https:\/\/doi.org\/10.3322\/caac.21492.","journal-title":"CA Cancer J Clin"},{"issue":"8","key":"376_CR3","doi-asserted-by":"publisher","first-page":"1654","DOI":"10.1002\/ijc.30869","volume":"141","author":"J Berntsson","year":"2017","unstructured":"Berntsson J, Svensson MC, Leandersson K, Nodin B, Micke P, Larsson AH, et al. The clinical impact of tumour-infiltrating lymphocytes in colorectal cancer differs by anatomical subsite: a cohort study. Int J Cancer. 2017;141(8):1654\u201366. https:\/\/doi.org\/10.1002\/ijc.30869.","journal-title":"Int J Cancer"},{"key":"376_CR4","doi-asserted-by":"publisher","first-page":"1595","DOI":"10.1038\/bjc.2014.46","volume":"110","author":"Z Mei","year":"2014","unstructured":"Mei Z, Liu Y, Liu C, Cui A, Liang Z, Wang G, et al. Tumour-infiltrating inflammation and prognosis in colorectal cancer: systematic review and meta-analysis. Br J Cancer. 2014;110:1595\u2013605. https:\/\/doi.org\/10.1038\/bjc.2014.46.","journal-title":"Br J Cancer"},{"key":"376_CR5","doi-asserted-by":"publisher","first-page":"7135","DOI":"10.4049\/jimmunol.175.11.7135","volume":"175","author":"RJ DiPaolo","year":"2005","unstructured":"DiPaolo RJ, Glass DD, Bijwaard KE, Shevach EM. CD4+CD25+ T cells prevent the development of organ-specific autoimmunedisease by inhibiting the differentiation of autoreactive effector T cells. J Immunol. 2005;175:7135\u201342. https:\/\/doi.org\/10.4049\/jimmunol.175.11.7135.","journal-title":"J Immunol"},{"key":"376_CR6","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1007\/3-540-27702-1_13","volume":"293","author":"T Nomura","year":"2005","unstructured":"Nomura T, Sakaguchi S. Naturally arising CD25+CD4+ regulatory T cells in tumor immunity. Curr Top Microbiol Immunol. 2005;293:287\u2013302. https:\/\/doi.org\/10.1007\/3-540-27702-1_13.","journal-title":"Curr Top Microbiol Immunol"},{"key":"376_CR7","doi-asserted-by":"publisher","first-page":"330","DOI":"10.1038\/ni904","volume":"4","author":"JD Fontenot","year":"2003","unstructured":"Fontenot JD, Gavin MA, Rudensky AY. Foxp3 programs the development and function of CD4+CD25+ regulatory T cells. Nat Immunol. 2003;4:330\u20136. https:\/\/doi.org\/10.1038\/ni904.","journal-title":"Nat Immunol"},{"key":"376_CR8","doi-asserted-by":"publisher","first-page":"8326","DOI":"10.1158\/1078-0432.CCR-05-1244","volume":"11","author":"D Wolf","year":"2005","unstructured":"Wolf D, Wolf AM, Rumpold H, Fiegl H, Zeimet AG, Muller-Holzner E, et al. The expression of the regulatory T cell-specific forkhead boxtranscription factor FoxP3 is associated with poor prognosis in ovarian cancer. Clin Cancer Res. 2005;11:8326\u201331. https:\/\/doi.org\/10.1158\/1078-0432.CCR-05-1244.","journal-title":"Clin Cancer Res"},{"key":"376_CR9","doi-asserted-by":"publisher","first-page":"5423","DOI":"10.1158\/1078-0432.CCR-06-0369","volume":"12","author":"N Hiraoka","year":"2006","unstructured":"Hiraoka N, Onozato K, Kosuge T, Hirohashi S. Prevalence of FOXP3+ regulatory T cells increases during the progression of pancreatic ductal adenocarcinoma and its premalignant lesions. Clin Cancer Res. 2006;12:5423\u201334. https:\/\/doi.org\/10.1158\/1078-0432.CCR-06-0369.","journal-title":"Clin Cancer Res"},{"key":"376_CR10","doi-asserted-by":"publisher","first-page":"625","DOI":"10.3892\/mco.2013.107","volume":"1","author":"M Takenaka","year":"2013","unstructured":"Takenaka M, Seki N, Toh U, HattoriS KA, Yamaguchi T, et al. FOXP3 expression in tumor cells and tumor-infiltrating lymphocytesis associated with breast cancer prognosis. Mol Clin Oncol. 2013;1:625\u201332. https:\/\/doi.org\/10.3892\/mco.2013.107.","journal-title":"Mol Clin Oncol"},{"key":"376_CR11","doi-asserted-by":"publisher","first-page":"1762","DOI":"10.1183\/13993003.00176-2014","volume":"46","author":"DS O\u2019callaghan","year":"2015","unstructured":"O\u2019callaghan DS, Rexhepaj E, Gately K, Coate L, Delaney D, O\u2019donnell DM, et al. Tumour islet Foxp3+ T-cell infiltration predictspoor outcome in nonsmall cell lung cancer. Eur Respir J. 2015;46:1762\u201372. doi. https:\/\/doi.org\/10.1183\/13993003.00176-2014.","journal-title":"Eur Respir J"},{"key":"376_CR12","doi-asserted-by":"publisher","first-page":"1960","DOI":"10.1126\/science.1129139","volume":"313","author":"J Galon","year":"2006","unstructured":"Galon J, Costes A, Sanchez-Cabo F, Kirilovsky A, Mlecnik B, Lagorce-Pag\u00e8s C, et al. Type, density, and location of immune cells within human colorectal tumors predict clinical outcome. Science. 2006;313:1960\u20134.","journal-title":"Science"},{"issue":"7","key":"376_CR13","doi-asserted-by":"publisher","first-page":"909","DOI":"10.1007\/s00262-011-1046-y","volume":"60","author":"S Ladoire","year":"2011","unstructured":"Ladoire S, Martin F, Ghiringhelli F. Prognostic role of FOXP3? Regulatory T cells infiltrating human carcinomas: the paradox of colorectal cancer. Cancer Immunol Immunother. 2011;60(7):909\u201318. Format: Abstract Cancer Immunol Immunother. https:\/\/doi.org\/10.1007\/s00262-011-1046-y.","journal-title":"Cancer Immunol Immunother"},{"key":"376_CR14","doi-asserted-by":"publisher","first-page":"2586","DOI":"10.1200\/JCO.2006.09.4565","volume":"25","author":"Q Gao","year":"2007","unstructured":"Gao Q, Qiu SJ, Fan J, Zhou J, Wang XY, Xiao YS, et al. Intratumoral balance of regulatory and cytotoxic T cells is associated with prognosis of hepatocellular carcinoma after resection. J Clin Oncol. 2007;25:2586\u201393.","journal-title":"J Clin Oncol"},{"key":"376_CR15","doi-asserted-by":"publisher","first-page":"15179","DOI":"10.1038\/srep15179","volume":"5","author":"B Shang","year":"2015","unstructured":"Shang B, Liu Y, Jiang SJ, Liu Y. Prognostic value of tumor-infiltrating FoxP3+ regulatory T cells in cancers: a systematic review and meta-analysis. Sci Rep. 2015;5:15179. https:\/\/doi.org\/10.1038\/srep15179.","journal-title":"Sci Rep"},{"key":"376_CR16","doi-asserted-by":"publisher","first-page":"2453","DOI":"10.3389\/fimmu.2019.02453","volume":"10","author":"CM Paluskievicz","year":"2019","unstructured":"Paluskievicz CM, Cao X, Abdi R, Zheng P, Liu Y, Bromberg JS. T regulatory cells and priming the suppressive tumor microenvironment. Front Immunol. 2019;10:2453. https:\/\/doi.org\/10.3389\/fimmu.2019.02453.","journal-title":"Front Immunol"},{"key":"376_CR17","first-page":"3491","volume":"58","author":"Y Naito","year":"1998","unstructured":"Naito Y, Saito K, Shiiba K, Ohuchi A, Saigenji K, Nagura H, et al. CD8 + T cells infiltrated within cancer cell nests as a prognostic factor in human colorectal cancer. Cancer Res. 1998;58:3491\u20134.","journal-title":"Cancer Res"},{"key":"376_CR18","doi-asserted-by":"publisher","unstructured":"Balic M, Thomssen C, W\u00fcrstlein R, Gnant M, Harbeck N. St. Gallen\/Vienna 2019: A brief summary of the consensus discussion on the optimal primary breast cancer treatment. Breast Care (Basel). 14(2):103\u201310. https:\/\/doi.org\/10.1159\/000499931.","DOI":"10.1159\/000499931"},{"key":"376_CR19","doi-asserted-by":"publisher","first-page":"212","DOI":"10.3322\/caac.20121","volume":"61","author":"R Siegel","year":"2011","unstructured":"Siegel R, Ward E, Brawley O, Jemal A. Cancer statistics, 2011: the impact of eliminating socioeconomic and racial disparities on premature cancer deaths. CA Cancer J Clin. 2011;61:212\u201336. https:\/\/doi.org\/10.3322\/caac.20121.","journal-title":"CA Cancer J Clin"},{"key":"376_CR20","doi-asserted-by":"publisher","first-page":"527","DOI":"10.1001\/archsurg.141.6.527","volume":"141","author":"AJ Bilchik","year":"2006","unstructured":"Bilchik AJ, DiNome M, Saha S, Turner R, Wiese D. Prospective multicenter trial of staging adequacy in colon cancer: preliminary results. Arch Surg. 2006;141:527\u201333.","journal-title":"Arch Surg"},{"key":"376_CR21","doi-asserted-by":"publisher","first-page":"1493","DOI":"10.1111\/j.1463-1318.2012.03048.x","volume":"14","author":"AG Powell","year":"2012","unstructured":"Powell AG, Wallace R, McKee RF, Anderson J, Going JJ, Edwards J, et al. The relationship between tumour site, clinicopathological characteristics, and cancer-specific survival in patients undergoing surgery for colorectal cancer. Color Dis. 2012;14:1493\u20139. https:\/\/doi.org\/10.1111\/j.1463-1318.2012.03048.x.","journal-title":"Color Dis"},{"key":"376_CR22","doi-asserted-by":"publisher","first-page":"5124","DOI":"10.1200\/JCO.2009.22.0467","volume":"27","author":"MS Roh","year":"2009","unstructured":"Roh MS, Colangelo LH, O\u2019Connell MJ, Yothers G, Deutsch M, et al. Preoperative multimodality therapy improves disease-free survival in patients with carcinoma of the rectum: NSABP R-03. J Clin Oncol. 2009;27:5124\u201330. https:\/\/doi.org\/10.1200\/JCO.2009.22.0467.","journal-title":"J Clin Oncol"},{"key":"376_CR23","doi-asserted-by":"publisher","first-page":"1731","DOI":"10.1056\/NEJMoa040694","volume":"351","author":"R Sauer","year":"2004","unstructured":"Sauer R, Becker H, Hohenberger W, Rodel C, Wittekind C, et al. Preoperative versus postoperative chemoradiotherapy for rectal cancer. N Engl J Med. 2004;351:1731\u201340.","journal-title":"N Engl J Med"},{"key":"376_CR24","doi-asserted-by":"publisher","first-page":"811","DOI":"10.1016\/S0140-6736(09)60484-0","volume":"373","author":"D Sebag-Montefiore","year":"2009","unstructured":"Sebag-Montefiore D, Stephens RJ, Steele R, Monson J, Grieve R, Khanna S, et al. Preoperative radiotherapy versus selective postoperative chemoradiotherapy in patients with rectal cancer (MRC CR07 and NCIC-CTG C016): a multicentre, randomised trial. Lancet. 2009;373:811\u201320. https:\/\/doi.org\/10.1016\/S0140-6736(09)60484-0.","journal-title":"Lancet"},{"key":"376_CR25","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1016\/S1357-4310(97)01191-X","volume":"4","author":"S Strand","year":"1998","unstructured":"Strand S, Galle PR. Immune evasion by tumours: involvement of the CD95 (APO-1\/Fas) system and its clinical implications. Mol Med Today. 1998;4:63\u20138. https:\/\/doi.org\/10.1016\/S1357-4310(97)01191-X.","journal-title":"Mol Med Today"},{"key":"376_CR26","first-page":"1781","volume":"7","author":"Z Liu","year":"2014","unstructured":"Liu Z, Huang Q, Liu G, Dang L, Chu D, et al. Presence of FOXP3+Treg cells is correlated with colorectal cancer progression. Int J Clin Exp Med. 2014;7:1781\u20135.","journal-title":"Int J Clin Exp Med"},{"key":"376_CR27","doi-asserted-by":"publisher","first-page":"653","DOI":"10.1007\/s00262-009-0781-9","volume":"59","author":"H Suzuki","year":"2010","unstructured":"Suzuki H, Chikazawa N, Tasaka T, Wada J, Yamasaki A, et al. Intratumoral CD8+ T\/FOXP3+ cell ratio is a predictive marker for survival in patients with colorectal cancer. Cancer Immunol Immunother. 2010;59:653\u201361. https:\/\/doi.org\/10.1007\/s00262-009-0781-9.","journal-title":"Cancer Immunol Immunother"},{"key":"376_CR28","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1186\/1748-717X-6-49","volume":"6","author":"K Yasuda","year":"2011","unstructured":"Yasuda K, Nirei T, Sunami E, Nagawa H, Kitayama J. Density of CD4(+) and CD8(+) T lymphocytes in biopsy samples can be a predictor of pathological response to chemoradiotherapy (CRT) for rectal cancer. Radiat Oncol. 2011;6:49.","journal-title":"Radiat Oncol"},{"key":"376_CR29","doi-asserted-by":"publisher","first-page":"1677","DOI":"10.1038\/bjc.2015.427","volume":"113","author":"MJ McCoy","year":"2015","unstructured":"McCoy MJ, Hemmings C, Miller TJ, Austin SJ, Bulsara MK, Zeps N, et al. Low stromal Foxp3+ regulatory T-cell density is associated with complete response to neoadjuvant chemoradiotherapy in rectal cancer. Br J Cancer. 2015;113:1677\u201386. https:\/\/doi.org\/10.1038\/bjc.2015.427.","journal-title":"Br J Cancer"},{"issue":"1","key":"376_CR30","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1186\/s12957-019-1621-9","volume":"17","author":"Y Zhao","year":"2019","unstructured":"Zhao Y, Ge X, He J, Cheng Y, Wang Z, Wang J, et al. The prognostic value of tumor-infiltrating lymphocytes in colorectal cancer differs by anatomical subsite: a systematic review and meta-analysis. World J Surg Oncol. 2019;17(1):85. https:\/\/doi.org\/10.1186\/s12957-019-1621-9.","journal-title":"World J Surg Oncol"}],"container-title":["Journal of Gastrointestinal Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12029-020-00376-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12029-020-00376-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12029-020-00376-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,8,10]],"date-time":"2021-08-10T13:07:12Z","timestamp":1628600832000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12029-020-00376-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,2,29]]},"references-count":30,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,3]]}},"alternative-id":["376"],"URL":"https:\/\/doi.org\/10.1007\/s12029-020-00376-1","relation":{},"ISSN":["1941-6628","1941-6636"],"issn-type":[{"value":"1941-6628","type":"print"},{"value":"1941-6636","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,2,29]]},"assertion":[{"value":"29 February 2020","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with Ethical Standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}}]}}